{"count": 19, "results": [{"_id": "40588059", "pmid": 40588059, "title": "Prepregnancy metformin use associated with lower risk of severe nausea and vomiting of pregnancy and hyperemesis gravidarum.", "journal": "Am J Obstet Gynecol", "authors": ["Sharma N", "MacGibbon KW", "Brecht-Doscher A", "Cortessis VK", "Fejzo MS"], "date": "2025-06-28T00:00:00Z", "doi": "10.1016/j.ajog.2025.06.055", "meta_date_publication": "2025 Jun 28", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50263.484, "text_hl": "Prepregnancy @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use associated with lower risk of severe @<m>DISEASE_Postoperative_Nausea_and_Vomiting</m> @DISEASE_MESH:D020250 @@@nausea and vomiting@@@ of pregnancy and @DISEASE_Hyperemesis_Gravidarum @DISEASE_MESH:D006939 @@@hyperemesis gravidarum@@@.", "citations": {"NLM": "Sharma N, MacGibbon KW, Brecht-Doscher A, Cortessis VK, Fejzo MS. Prepregnancy metformin use associated with lower risk of severe nausea and vomiting of pregnancy and hyperemesis gravidarum. Am J Obstet Gynecol. 2025 Jun 28;():. PMID: 40588059", "BibTeX": "@article{40588059, title={Prepregnancy metformin use associated with lower risk of severe nausea and vomiting of pregnancy and hyperemesis gravidarum.}, author={Sharma N and MacGibbon KW and Brecht-Doscher A and Cortessis VK and Fejzo MS}, journal={Am J Obstet Gynecol}}"}}, {"_id": "37923756", "pmid": 37923756, "pmcid": "PMC10624877", "title": "Efficacy and safety of polyethylene glycol loxenatide in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials", "journal": "Sci Rep", "authors": ["Salamah HM", "Marey A", "Elsayed E", "Hasan MT", "Mahmoud A", "Abualkhair KA", "Abo-Elnour DE", "Abdelhaleem IA", "Abd-Elgawad M"], "date": "2023-11-03T00:00:00Z", "doi": "10.1038/s41598-023-46274-x", "meta_date_publication": "2023 Nov 3", "meta_volume": "13", "meta_issue": "1", "meta_pages": "19041", "score": 50260.55, "text_hl": "People who received @CHEMICAL_polyethylene_glycol_loxenatide @CHEMICAL_MESH:C000601947 @@@PEX168@@@ alone or with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ showed more common @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal adverse effects@@@, especially @<m>DISEASE_Postoperative_Nausea_and_Vomiting</m> @DISEASE_MESH:D020250 @@@nausea and vomiting@@@ (p < 0.05). ", "citations": {"NLM": "Salamah HM, Marey A, Elsayed E, Hasan MT, Mahmoud A, Abualkhair KA, Abo-Elnour DE, Abdelhaleem IA, Abd-Elgawad M. Efficacy and safety of polyethylene glycol loxenatide in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials Sci Rep. 2023 Nov 3;13(1):19041. PMID: 37923756", "BibTeX": "@article{37923756, title={Efficacy and safety of polyethylene glycol loxenatide in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials}, author={Salamah HM and Marey A and Elsayed E and Hasan MT and Mahmoud A and Abualkhair KA and Abo-Elnour DE and Abdelhaleem IA and Abd-Elgawad M}, journal={Sci Rep}, volume={13}, number={1}, pages={19041}}"}}, {"_id": "36458118", "pmid": 36458118, "pmcid": "PMC9705964", "title": "The role of metformin in treatment of weight gain associated with atypical antipsychotic treatment in children and adolescents: A systematic review and meta-analysis of randomized controlled trials", "journal": "Front Psychiatry", "authors": ["Mansuri Z", "Makani R", "Trivedi C", "Adnan M", "Vadukapuram R", "Rafael J", "Lodhi A", "Reddy A"], "date": "2022-11-15T00:00:00Z", "doi": "10.3389/fpsyt.2022.933570", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "933570", "score": 50254.24, "text_hl": "There were higher odds of @<m>DISEASE_Postoperative_Nausea_and_Vomiting</m> @DISEASE_MESH:D020250 @@@nausea-vomiting@@@ [OR: 4.07, CI: 1.32-12.54, p-value: 0.02] and @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@ [OR: 2.93, CI: 1.50-5.71, p-value: 0.002] in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group. ", "citations": {"NLM": "Mansuri Z, Makani R, Trivedi C, Adnan M, Vadukapuram R, Rafael J, Lodhi A, Reddy A. The role of metformin in treatment of weight gain associated with atypical antipsychotic treatment in children and adolescents: A systematic review and meta-analysis of randomized controlled trials Front Psychiatry. 2022;13():933570. PMID: 36458118", "BibTeX": "@article{36458118, title={The role of metformin in treatment of weight gain associated with atypical antipsychotic treatment in children and adolescents: A systematic review and meta-analysis of randomized controlled trials}, author={Mansuri Z and Makani R and Trivedi C and Adnan M and Vadukapuram R and Rafael J and Lodhi A and Reddy A}, journal={Front Psychiatry}, volume={13}, pages={933570}}"}}, {"_id": "40443168", "pmid": 40443168, "title": "Metformin for the Prevention of Hyperemesis Gravidarum: An Observational Cohort Study.", "journal": "BJOG", "authors": ["Sillis L", "Heinonen EW", "Ceulemans M", "Johnson D", "Luo Y", "Chambers CD"], "date": "2025-05-29T00:00:00Z", "doi": "10.1111/1471-0528.18238", "meta_date_publication": "2025 May 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50252.387, "text_hl": "OBJECTIVE: To evaluate if @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment prior to pregnancy reduces the likelihood of @<m>DISEASE_Postoperative_Nausea_and_Vomiting</m> @DISEASE_MESH:D020250 @@@nausea and vomiting@@@ in pregnancy (NVP) and @DISEASE_Hyperemesis_Gravidarum @DISEASE_MESH:D006939 @@@hyperemesis gravidarum@@@ (@DISEASE_Hyperemesis_Gravidarum @DISEASE_MESH:D006939 @@@HG@@@) compared to no exposure. ", "citations": {"NLM": "Sillis L, Heinonen EW, Ceulemans M, Johnson D, Luo Y, Chambers CD. Metformin for the Prevention of Hyperemesis Gravidarum: An Observational Cohort Study. BJOG. 2025 May 29;():. PMID: 40443168", "BibTeX": "@article{40443168, title={Metformin for the Prevention of Hyperemesis Gravidarum: An Observational Cohort Study.}, author={Sillis L and Heinonen EW and Ceulemans M and Johnson D and Luo Y and Chambers CD}, journal={BJOG}}"}}, {"_id": "32738838", "pmid": 32738838, "title": "Study of Diversity of Metformin Related Gastrointestinal Side Effects.", "journal": "J Assoc Physicians India", "authors": ["Saluja M", "Pareek KK", "Swami YK"], "date": "2020-08-01T00:00:00Z", "meta_date_publication": "2020 Aug", "meta_volume": "68", "meta_issue": "8", "meta_pages": "36-38", "score": 50252.383, "text_hl": "This study is to estimate @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ related GI side effects in Indian population. ", "citations": {"NLM": "Saluja M, Pareek KK, Swami YK. Study of Diversity of Metformin Related Gastrointestinal Side Effects. J Assoc Physicians India. 2020 Aug;68(8):36-38. PMID: 32738838", "BibTeX": "@article{32738838, title={Study of Diversity of Metformin Related Gastrointestinal Side Effects.}, author={Saluja M and Pareek KK and Swami YK}, journal={J Assoc Physicians India}, volume={68}, number={8}, pages={36-38}}"}}, {"_id": "32157435", "pmid": 32157435, "title": "An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases.", "journal": "J Cancer Res Clin Oncol", "authors": ["Broadhurst PJ", "Hart AR"], "date": "2020-05-01T00:00:00Z", "doi": "10.1007/s00432-020-03177-y", "meta_date_publication": "2020 May", "meta_volume": "146", "meta_issue": "5", "meta_pages": "1369-1375", "score": 50252.19, "text_hl": "Characteristics were similar between non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users. ", "citations": {"NLM": "Broadhurst PJ, Hart AR. An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases. J Cancer Res Clin Oncol. 2020 May;146(5):1369-1375. PMID: 32157435", "BibTeX": "@article{32157435, title={An observational study to justify and plan a future phase III randomized controlled trial of metformin in improving overall survival in patients with inoperable pancreatic cancer without liver metastases.}, author={Broadhurst PJ and Hart AR}, journal={J Cancer Res Clin Oncol}, volume={146}, number={5}, pages={1369-1375}}"}}, {"_id": "36575901", "pmid": 36575901, "title": "Metformin-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion.", "journal": "Br J Clin Pharmacol", "authors": ["Koslover J", "Bruce D", "Patel S", "Webb AJ"], "date": "2022-12-27T00:00:00Z", "doi": "10.1111/bcp.15653", "meta_date_publication": "2022 Dec 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50245.617, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion.", "citations": {"NLM": "Koslover J, Bruce D, Patel S, Webb AJ. Metformin-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion. Br J Clin Pharmacol. 2022 Dec 27;():. PMID: 36575901", "BibTeX": "@article{36575901, title={Metformin-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion.}, author={Koslover J and Bruce D and Patel S and Webb AJ}, journal={Br J Clin Pharmacol}}"}}, {"_id": "3359923", "pmid": 3359923, "title": "Metformin in the digestive tract.", "journal": "Diabetes Res Clin Pract", "authors": ["Vidon N", "Chaussade S", "Noel M", "Franchisseur C", "Huchet B", "Bernier JJ"], "date": "1988-02-19T00:00:00Z", "doi": "10.1016/s0168-8227(88)80022-6", "meta_date_publication": "1988 Feb 19", "meta_volume": "4", "meta_issue": "3", "meta_pages": "223-9", "score": 50063.43, "text_hl": "...After ingestion of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, a drug of the @CHEMICAL_Biguanides @CHEMICAL_MESH:D001645 @@@biguanide@@@ class, there are @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal effects@@@ in the form of @<m>DISEASE_Postoperative_Nausea_and_Vomiting</m> @DISEASE_MESH:D020250 @@@nausea and vomiting@@@, and about 30% of the drug is recovered in feces. ", "citations": {"NLM": "Vidon N, Chaussade S, Noel M, Franchisseur C, Huchet B, Bernier JJ. Metformin in the digestive tract. Diabetes Res Clin Pract. 1988 Feb 19;4(3):223-9. PMID: 3359923", "BibTeX": "@article{3359923, title={Metformin in the digestive tract.}, author={Vidon N and Chaussade S and Noel M and Franchisseur C and Huchet B and Bernier JJ}, journal={Diabetes Res Clin Pract}, volume={4}, number={3}, pages={223-9}}"}}, {"_id": "14624284", "pmid": 14624284, "title": "Ondansetron and metformin-induced gastrointestinal side effects.", "journal": "Am J Ther", "authors": ["Hoffmann IS", "Roa M", "Torrico F", "Cubeddu LX"], "date": "2003-11-01T00:00:00Z", "doi": "10.1097/00045391-200311000-00012", "meta_date_publication": "2003 Nov-Dec", "meta_volume": "10", "meta_issue": "6", "meta_pages": "447-51", "score": 50050.656, "text_hl": "Of the 98 subjects treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, 22 developed side effects to match the study entry criteria. ", "citations": {"NLM": "Hoffmann IS, Roa M, Torrico F, Cubeddu LX. Ondansetron and metformin-induced gastrointestinal side effects. Am J Ther. 2003 Nov-Dec;10(6):447-51. PMID: 14624284", "BibTeX": "@article{14624284, title={Ondansetron and metformin-induced gastrointestinal side effects.}, author={Hoffmann IS and Roa M and Torrico F and Cubeddu LX}, journal={Am J Ther}, volume={10}, number={6}, pages={447-51}}"}}, {"_id": "14576245", "pmid": 14576245, "title": "Metformin in polycystic ovary syndrome: systematic review and meta-analysis.", "journal": "BMJ", "authors": ["Lord JM", "Flight IH", "Norman RJ"], "date": "2003-10-25T00:00:00Z", "doi": "10.1136/bmj.327.7421.951", "meta_date_publication": "2003 Oct 25", "meta_volume": "327", "meta_issue": "7421", "meta_pages": "951-3", "score": 50050.508, "text_hl": "We found no evidence of any effect on body mass index or waist:hip ratio. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ was associated with a higher incidence of @<m>DISEASE_Postoperative_Nausea_and_Vomiting</m> @DISEASE_MESH:D020250 @@@nausea, vomiting@@@, and other @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal disturbance@@@. ", "citations": {"NLM": "Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003 Oct 25;327(7421):951-3. PMID: 14576245", "BibTeX": "@article{14576245, title={Metformin in polycystic ovary syndrome: systematic review and meta-analysis.}, author={Lord JM and Flight IH and Norman RJ}, journal={BMJ}, volume={327}, number={7421}, pages={951-3}}"}}]}